Compare Illumina, Inc. (ILMN) vs SYSCO Corporation (SYY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs SYSCO Corporation — how do they compare? Illumina, Inc. trades at $191.04 (market cap $27.94B), while SYSCO Corporation trades at $81.28 (market cap $38.63B). The key difference: SYSCO Corporation is the larger of the two by market cap, and SYSCO Corporation pays a 2.72% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | SYY | |
|---|---|---|
Market Cap | $27.94B | $38.63B |
Sector | Health | Consumer Staples |
52-Week High | $194.33 | $91.16 |
52-Week Low | $91.00 | $69.30 |
Enterprise Value | $29.33B | $52.11B |
Dividend Yield | — | 2.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
SYY trades at $81.02, down 0.82% on the day, with a neutral technical signal and support at $81. The company reported $81.37B in revenue for 2025 with a net margin of 2.08%, and upcoming Q4 2026 earnings on August 4 are expected at $1.51 EPS. Positive cash flow trends and a dividend of $0.55 payable July 24 provide stability, while analyst consensus is bullish with a $84.75 price target.
Outlook is cautiously optimistic given analyst buy ratings (60%) and steady revenue growth, but risks include thin profit margins and high debt levels. The stock offers value with a P/S of 0.47, though near-term performance hinges on earnings results and macroeconomic conditions affecting the food distribution sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About SYSCO Corporation
Sysco is the largest U.S. food-service distributor, boasting 17% market share of the highly fragmented food-service distribution industry. Sysco distributes over 400,000 food and nonfood products to restaurants (63% of revenue), healthcare facilities (8%), education and government buildings (8%), travel and leisure (7%), and other locations (14%) where individuals consume away-from-home meals. In fiscal 2022, 82% of the firm's revenue was U.S.-based, with 7% from Canada, 4% from the U.K., 2% from France, and 4% other.
Read more on SYY →
